Effects of argatroban and heparin on thrombus formation and tissue plasminogen activator-induced thrombolysis in a microvascular thrombosis model

By Yamada K.   Tsuji H.   Kimura S.   Kato H.   Yano S.   Ukimura N.   Yamada Y.   Nakagawa K.   Nakagawa M.  

Thrombosis Research, Vol. 109, Iss. 1, 2003-01 ,pp. : 55-64

Elsevier

Access to resources Recommend Favorite

Heparin cofactor II in patients with deep venous thrombosis under heparin and oral anticoagulant therapy

By Toulon P.   Vitoux J.F.   Capron L.   Roncato M.   Fiessinger J.N.   Aiach M.  

Thrombosis Research, Vol. 49, Iss. 5, 1998-03 ,pp. : 497-500

Elsevier

Access to resources Recommend Favorite

Anticoagulant and Antithrombin Effects of Intimatan, a Heparin Cofactor II Agonist

By Buchanan M.R.   Brister S.J.  

Thrombosis Research, Vol. 99, Iss. 6, 2000-09 ,pp. : 603-612

Elsevier

Access to resources Recommend Favorite

SULFATED POLYSACCHARIDE FROM THE LEAVES OF ARTEMISIA PRINCEPS ACTIVATES HEPARIN COFACTOR II INDEPENDENTLY OF THE LYS 173 and ARG 189 RESIDUES OF HEPARIN COFACTOR II

By Hayashi T.   Hayakawa Y.   Hayashi T.   Sasaki H.   Sakuragawa N.  

Thrombosis Research, Vol. 87, Iss. 1, 1997-07 ,pp. : 105-112

Elsevier

Access to resources Recommend Favorite

ACTIVE SITE FOR HEPARIN COFACTOR II IN LOW MOLECULAR MASS DERMATAN SULFATE. CONTRIBUTION TO THE ANTITHROMBOTIC ACTIVITY OF FRACTIONS WITH HIGH AFFINITY FOR HEPARIN COFACTOR II

By Mascellani G.   Liverani L.   Parma B.   Bergonzini G.   Bianchini P.  

Thrombosis Research, Vol. 84, Iss. 1, 1996-10 ,pp. : 21-32

Elsevier

Access to resources Recommend Favorite